Literature DB >> 17389443

Health care use and risk of ovarian cancer: is there a link?

Michael Fung-Kee-Fung1, Melissa Brouwers, Thomas K Oliver, Barry Rosen.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17389443      PMCID： PMC1828185          DOI： 10.1503/cmaj.070179

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  ACOG Committee Opinion: number 280, December 2002. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer.

Authors: 
Journal:  Obstet Gynecol       Date:  2002-12       Impact factor: 7.661

2.  Screening for ovarian cancer: recommendation statement. U.S. Preventive Services Task Force.

Authors: 
Journal:  Am Fam Physician       Date:  2005-02-15       Impact factor: 3.292

Review 3.  A review and an update on the screening of epithelial ovarian cancer.

Authors:  Evelyn A Reynolds; Karen A Moller
Journal:  Curr Probl Cancer       Date:  2006 Sep-Oct       Impact factor: 3.187

4.  Ovarian cancer risk in relation to medical visits, pelvic examinations and type of health care provider.

Authors:  Haim A Abenhaim; Linda Titus-Ernstoff; Daniel W Cramer
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

Review 5.  Ovarian cancer screening.

Authors:  M Kyrgiou; I Tsoumpou; P Martin-Hirsch; M Arbyn; W Prendiville; G Koliopoulos; N Dalkalitsis; P Stamatopoulos; E Paraskevaidis
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

6.  The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation.

Authors:  G P Browman; M N Levine; E A Mohide; R S Hayward; K I Pritchard; A Gafni; A Laupacis
Journal:  J Clin Oncol       Date:  1995-02       Impact factor: 44.544

7.  Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback.

Authors:  G P Browman; T E Newman; E A Mohide; I D Graham; M N Levine; K I Pritchard; W K Evans; J A Maroun; D I Hodson; M S Carey; D H Cowan
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

Review 8.  Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses.

Authors:  Laurie Elit; Thomas K Oliver; Allan Covens; Janice Kwon; Michael Fung-Kee Fung; Holger W Hirte; Amit M Oza
Journal:  Cancer       Date:  2007-02-15       Impact factor: 6.860

Review 9.  Screening postmenopausal women for ovarian cancer: a systematic review.

Authors:  Michael Fung Kee Fung; Peter Bryson; Mary Johnston; Alexandra Chambers
Journal:  J Obstet Gynaecol Can       Date:  2004-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.